U.S. sales of morning-after pill double

Jul 13, 2007

Sales of the morning-after pill Plan B in the United States have doubled since it was made available without a prescription.

Drug maker Barr Pharmaceuticals said sales will probably be close to $80 million for 2007, The Washington Post said Friday.

The Food and Drug Administration approved the sale of the controversial emergency contraceptive without a prescription for women 18 and older last August.

Women's health and family-planning advocates say it illustrates the value of easing access to birth control to help prevent unwanted pregnancies, the newspaper said.

Conservative groups, however, question the drug's safety and maintain the pill can cause the equivalent of an abortion.

Advocates would like to see the FDA remove the age restriction.

Copyright 2007 by United Press International

Explore further: Determine patient preferences by means of conjoint analysis

add to favorites email to friend print save as pdf

Related Stories

Con artist who helped Google probe to be sentenced

Oct 23, 2011

(AP) -- A massive federal investigation that resulted in Google Inc. forfeiting $500 million this year to settle criminal claims over its advertising began with the 2008 arrest of a jet-setting career con artist, who took ...

30 years after first AIDS cases, hope for a cure

Jun 03, 2011

(AP) -- Sunday marks 30 years since the first AIDS cases were reported in the United States. And this anniversary brings fresh hope for something many had come to think was impossible: finding a cure.

US aims at its deadliest drug problem: painkillers

Apr 20, 2011

(AP) -- The White House drug czar wants doctors, states and law enforcement working harder to stop America's deadliest drug-abuse problem: highly addictive prescription painkillers. They are killing more ...

Watchdog group makes 2nd push to ban diet pill

Apr 18, 2011

(AP) -- For the second time in five years, public health advocates are calling on the Food and Drug Administration to ban a fat-blocking drug sold over-the counter and via prescription, pointing to new reports of kidney ...

Recommended for you

Determine patient preferences by means of conjoint analysis

Jul 29, 2014

The Conjoint Analysis (CA) method is in principle suitable to find out which preferences patients have regarding treatment goals. However, to widely use it in health economic evaluations, some (primarily methodological) issues ...

FDA approves hard-to-abuse narcotic painkiller

Jul 25, 2014

(HealthDay)—A new formulation of a powerful narcotic painkiller that discourages potential abusers from snorting or injecting the drug has been approved by the U.S. Food and Drug Administration.

Race affects opioid selection for cancer pain

Jul 25, 2014

(HealthDay)—Racial disparities exist in the type of opioid prescribed for cancer pain, according to a study published online July 21 in the Journal of Clinical Oncology.

FDA approves tough-to-abuse formulation of oxycodone

Jul 25, 2014

(HealthDay)—Targiniq ER (oxycodone hydrochloride and naloxone hydrochloride extended release) has been approved by the U.S. Food and Drug Administration as a long-term, around-the-clock treatment for severe ...

User comments : 0